High-performance liquid chromatographic method for the determination of sorafenib in human serum and peritoneal fluid.
about
Active Targeting of Sorafenib: Preparation, Characterization, and In Vitro Testing of Drug-Loaded Magnetic Solid Lipid Nanoparticles.Quantitation of VEGFR2 (vascular endothelial growth factor receptor) inhibitors--review of assay methodologies and perspectives.Quantitative and qualitative analysis of the novel antitumor 1,3,4-oxadiazole derivative (GLB) and its metabolites using HPLC-UV and UPLC-QTOF-MS.An LC-MS/MS method for rapid and sensitive high-throughput simultaneous determination of various protein kinase inhibitors in human plasma.Immune modulation of effector CD4+ and regulatory T cell function by sorafenib in patients with hepatocellular carcinoma.Drug safety evaluation of sorafenib for treatment of solid tumors: consequences for the risk assessment and management of cancer patients.Targeted therapy for human hepatic carcinoma cells using folate-functionalized polymeric micelles loaded with superparamagnetic iron oxide and sorafenib in vitro.Clinical pharmacokinetics of tyrosine kinase inhibitors: focus on pyrimidines, pyridines and pyrroles.Sorafenib perpetuates cellular anticancer effector functions by modulating the crosstalk between macrophages and natural killer cells.Measurement of sorafenib plasma concentration by high-performance liquid chromatography in patients with advanced hepatocellular carcinoma: is it useful the application in clinical practice? A pilot study.Quantitative Estimation of Sorafenib Tosylate Its Pure Form and in Its Tablet Formulation by RP-HPLC Method
P2860
Q30964683-342B456B-F83E-45FD-976E-45561FDA3C27Q35450340-CCEE81CE-43DE-4F58-AE1B-4DFD5BDE647FQ35824959-F077E770-918B-40B5-A278-B87A7F3F748BQ36083906-8BEFC645-233E-4F68-BF3C-653E1166C399Q37393627-57788107-8D29-4005-BF8B-57EFCDA916CFQ38201503-AA782B38-03A7-4D9E-A2B2-B9636C1151CFQ40019239-823C3224-0FDA-4514-A97B-304DAFBE6B31Q43841175-6139FD33-7CA5-4A83-9E65-DB3986E012D4Q46107681-BCA04CE3-9D6B-4CD0-9A43-476AE94FF512Q51007060-415C4E51-ED7F-4F64-A1DA-0F42638CDDCEQ59008526-1CE46856-275F-40EA-B6E8-DF1FD6B3C42D
P2860
High-performance liquid chromatographic method for the determination of sorafenib in human serum and peritoneal fluid.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
High-performance liquid chroma ...... an serum and peritoneal fluid.
@en
High-performance liquid chroma ...... an serum and peritoneal fluid.
@nl
type
label
High-performance liquid chroma ...... an serum and peritoneal fluid.
@en
High-performance liquid chroma ...... an serum and peritoneal fluid.
@nl
prefLabel
High-performance liquid chroma ...... an serum and peritoneal fluid.
@en
High-performance liquid chroma ...... an serum and peritoneal fluid.
@nl
P2093
P2860
P1476
High-performance liquid chroma ...... an serum and peritoneal fluid.
@en
P2093
Annegret Helle-Beyersdorf
Daniela Keller
Diana Schirmer
Hartwig Klinker
Kathrin Kahle
Peter Langmann
Ulrike Lenker
P2860
P2888
P304
P356
10.1007/S00280-010-1474-Y
P577
2010-10-07T00:00:00Z